Pirmal Healthcare Ltd. has initiated a course in clinical research at the Harvard School of Public Health. The course initiated by Swati Piramal, director of Piramal Healthcare Ltd, will be an online course, aimed at widening the
A lot of noise is being made about the Piramal's recent acquisition of Bayer's molecular imaging portfolio but what does it really imply?
According to chairman Mr Ajay Piramal it’s a shift from being a maker of branded
There seems to be some major shakeups in the healthcare sector. Yesterday Piramal Health acquired Bayer's molecular imaging portfolio and now Agnivesh Agarwal, a member of the founding family of the $11.4 billion-turnover
Piramal announced that it has signed an agreement to acquire worldwide rights to the molecular imaging research and development portfolio of Bayer through its newly created subsidiary – Piramal Imaging SA. The portfolio